Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and-2: Significant contribution of MASP-1 to lectin pathway activation

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 4169-4178

  Kocsis, Andrea ^a   Kekési, Katalin A ^b   Szász, Róbert ^c   Végh, Barbara M ^a   Balczer, Júlia ^a   Dobó, József ^a   Závodszky, Péter ^a   Gál, Péter ^a   Pál, Gábor ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; ENZYME PRECURSOR; LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 1; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; SERINE PROTEINASE INHIBITOR; SUNFLOWER MASP INHIBITOR 1; SUNFLOWER MASP INHIBITOR 2; UNCLASSIFIED DRUG; MASP1 PROTEIN, HUMAN; MASP2 PROTEIN, HUMAN; PEPTIDE LIBRARY; PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING; COMPLEMENT DEPOSITION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; COMPLEMENT LECTIN PATHWAY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION; PROTEASE INHIBITORS;

EID: 77958128617     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001819     Document Type: Article

References (66)

1. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344:1058-1066.
2. Gál, P., L. Barna, A. Kocsis, and P. Závodszky. 2007. Serine proteases of the classical and lectin pathways: similarities and differences. Immunobiology 212:267-277.
3. Wallis, R., D. A. Mitchell, R. Schmid, W. J. Schwaeble, and A. H. Keeble. 2010. Paths reunited: initiation of the classical and lectin pathways of complement activation. Immunobiology 215:1-11.
4. Spitzer, D., L. M. Mitchell, J. P. Atkinson, and D. E. Hourcade. 2007. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J. Immunol. 179:2600-2608.
5. Thiel, S. 2007. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 44:3875-3888.
6. Garred, P., C. Honoré, Y. J. Ma, L. Munthe-Fog, and T. Hummelshøj. 2009. MBL2, FCN1, FCN2 and FCN3-the genes behind the initiation of the lectin pathway of complement. Mol. Immunol. 46:2737-2744.
7. Gál, P., J. Dobó, P. Závodszky, and R. B. Sim. 2009. Early complement proteases: C1r, C1s and MASPs-a structural insight into activation and functions. Mol. Immunol. 46:2745-2752.
8. Degn, S. E., A. G. Hansen, R. Steffensen, C. Jacobsen, J. C. Jensenius, and S. Thiel. 2009. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J. Immunol. 183:7371-7378.
9. Chen, C. B., and R. Wallis. 2001. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases: defining functional units for complement activation. J. Biol. Chem. 276:25894-25902.
10. Ambrus, G., P. Gál, M. Kojima, K. Szilágyi, J. Balczer, J. Antal, L. Gráf, A. Laich, B. E. Moffatt, W. Schwaeble, et al. 2003. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and-2: a study on recombinant catalytic fragments. J. Immunol. 170:1374-1382.
11. Matsushita, M., S. Thiel, J. C. Jensenius, I. Terai, and T. Fujita. 2000. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 165:2637-2642.
12. Hajela, K., M. Kojima, G. Ambrus, K. H. Wong, B. E. Moffatt, J. Ferluga, S. Hajela, P. Gál, and R. B. Sim. 2002. The biological functions of MBL-associated serine proteases (MASPs). Immunobiology 205:467-475.
13. Krarup, A., K. C. Gulla, P. Gál, K. Hajela, and R. B. Sim. 2008. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. Biochim. Biophys. Acta 1784:1294-1300.
14. Megyeri, M., V. Makó, L. Beinrohr, Z. Doleschall, Z. Prohászka, L. Cervenak, P. Závodszky, and P. Gál. 2009. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J. Immunol. 183:3409-3416.
15. Takahashi, M., D. Iwaki, K. Kanno, Y. Ishida, J. Xiong, M. Matsushita, Y. Endo, S. Miura, N. Ishii, K. Sugamura, and T. Fujita. 2008. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J. Immunol. 180:6132-6138.
16. Møller-Kristensen, M., S. Thiel, A. Sjöholm, M. Matsushita, and J. C. Jensenius. 2007. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int. Immunol. 19:141-149.
17. Skjoedt, M. O., T. Hummelshoj, Y. Palarasah, C. Honore, C. Koch, K. Skjodt, and P. Garred. 2010. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J. Biol. Chem. 285:8234-8243.
18. Skjoedt, M. O., Y. Palarasah, L. Munthe-Fog, Y. Jie Ma, G. Weiss, K. Skjodt, C. Koch, and P. Garred. 2009. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation. Immunobiology.
19. Mastellos, D., and J. D. Lambris. 2002. Complement: more than a "guard" against invading pathogens? Trends Immunol. 23:485-491.
20. Stevens, B., N. J. Allen, L. E. Vazquez, G. R. Howell, K. S. Christopherson, N. Nouri, K. D. Micheva, A. K. Mehalow, A. D. Huberman, B. Stafford, et al. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-1178.
21. Ricklin, D., and J. D. Lambris. 2007. Complement-targeted therapeutics. Nat. Biotechnol. 25:1265-1275.
22. Walsh, M. C., T. Bourcier, K. Takahashi, L. Shi, M. N. Busche, R. P. Rother, S. D. Solomon, R. A. B. Ezekowitz, and G. L. Stahl. 2005. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J. Immunol. 175:541-546.
23. Wagner, E., and M. M. Frank. 2010. Therapeutic potential of complement modulation. Nat. Rev. Drug Discov. 9:43-56.
24. Beinrohr, L., J. Dobó, P. Závodszky, and P. Gál. 2008. C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends Mol. Med. 14:511-521.
25. Qu, H., D. Ricklin, and J. D. Lambris. 2009. Recent developments in low molecular weight complement inhibitors. Mol. Immunol. 47:185-195.
26. Schwertz, H., J. M. Carter, M. Russ, S. Schubert, A. Schlitt, U. Buerke, M. Schmidt, H. Hillen, K. Werdan, and M. Buerke. 2008. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition. J. Cardiovasc. Pharmacol. 52:151-160.
27. Korsinczky, M. L., H. J. Schirra, K. J. Rosengren, J. West, B. A. Condie, L. Otvos, M. A. Anderson, and D. J. Craik. 2001. Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. J. Mol. Biol. 311:579-591.
28. Luckett, S., R. S. Garcia, J. J. Barker, A. V. Konarev, P. R. Shewry, A. R. Clarke, and R. L. Brady. 1999. High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. J. Mol. Biol. 290:525-533.
29. Marx, U. C., M. L. Korsinczky, H. J. Schirra, A. Jones, B. Condie, L. Otvos, Jr., and D. J. Craik. 2003. Enzymatic cyclization of a potent Bowman-Birk protease inhibitor, sunflower trypsin inhibitor-1, and solution structure of an acyclic precursor peptide. J. Biol. Chem. 278:21782-21789.
30. Mulvenna, J. P., F. M. Foley, and D. J. Craik. 2005. Discovery, structural determination, and putative processing of the precursor protein that produces the cyclic trypsin inhibitor sunflower trypsin inhibitor 1. J. Biol. Chem. 280:32245-32253.
31. Szenthe, B., A. Patthy, Z. Gáspári, A. K. Kékesi, L. Gráf, and G. Pál. 2007. When the surface tells what lies beneath: combinatorial phage-display mutagenesis reveals complex networks of surface-core interactions in the pacifastin protease inhibitor family. J. Mol. Biol. 370:63-79.
32. Sidhu, S. S., H. B. Lowman, B. C. Cunningham, and J. A. Wells. 2000. Phage display for selection of novel binding peptides. Methods Enzymol. 328:333-363.
33. Crooks, G. E., G. Hon, J. M. Chandonia, and S. E. Brenner. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188-1190.
34. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:161-214.
35. Seelen, M. A., A. Roos, J. Wieslander, T. E. Mollnes, A. G. Sjöholm, R. Wurzner, M. Loos, F. Tedesco, R. B. Sim, P. Garred, et al. 2005. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 296:187-198.
36. Empie, M. W., and M. Laskowski, Jr. 1982. Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: effect on inhibitor interactions with serine proteinases. Biochemistry 21:2274-2284.
37. Presanis, J. S., K. Hajela, G. Ambrus, P. Gál, and R. B. Sim. 2004. Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol. Immunol. 40:921-929.
38. Dobó, J., V. Harmat, L. Beinrohr, E. Sebestyén, P. Závodszky, and P. Gál. 2009. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J. Immunol. 183:1207-1214.
39. Gál, P., V. Harmat, A. Kocsis, T. Bián, L. Barna, G. Ambrus, B. Végh, J. Balczer, R. B. Sim, G. Náray-Szabó, and P. Závodszky. 2005. A true autoactivating enzyme: structural insight into mannose-binding lectin-associated serine protease-2 activations. J. Biol. Chem. 280:33435-33444.
40. Harmat, V., P. Gal, J. Kardos, K. Szilagyi, G. Ambrus, B. Vegh, G. Naray-Szabo, and P. Zavodszky. 2004. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions. J. Mol. Biol. 342:1533-1546.
41. Legowska, A., E. Bulak, M. Wysocka, A. Jaśkiewicz, A. Lesner, D. Debowski, and K. Rolka. 2008. Peptomeric analogues of trypsin inhibitor SFTI-1 isolated from sunflower seeds. Bioorg. Med. Chem. 16:5644-5652.
42. Zabłotna, E., K. Kažmierczak, A. Jaśkiewicz, M. Stawikowski, G. Kupryszewski, and K. Rolka. 2002. Chemical synthesis and kinetic study of the smallest naturally occurring trypsin inhibitor SFTI-1 isolated from sunflower seeds and its analogues. Biochem. Biophys. Res. Commun. 292:855-859.
43. Schechter, I., and A. Berger. 1967. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:157-162.
44. Brauer, A. B., G. J. Domingo, R. M. Cooke, S. J. Matthews, and R. J. Leatherbarrow. 2002. A conserved cis peptide bond is necessary for the activity of Bowman-Birk inhibitor protein. Biochemistry 41:10608-10615.
45. Brauer, A. B., and R. J. Leatherbarrow. 2003. The conserved P1' Ser of Bowman-Birk-type proteinase inhibitors is not essential for the integrity of the reactive site loop. Biochem. Biophys. Res. Commun. 308:300-305.
46. Brauer, A. B., M. Nievo, J. D. McBride, and R. J. Leatherbarrow. 2003. The structural basis of a conserved P2 threonine in canonical serine proteinase inhibitors. J. Biomol. Struct. Dyn. 20:645-656.
47. McBride, J. D., A. B. Brauer, M. Nievo, and R. J. Leatherbarrow. 1998. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop. J. Mol. Biol. 282:447-458.
48. McBride, J. D., E. M. Watson, A. B. Brauer, A. M. Jaulent, and R. J. Leatherbarrow. 2002. Peptide mimics of the Bowman-Birk inhibitor reactive site loop. Biopolymers 66:79-92.
49. Philipp, S., Y. M. Kim, I. Durr, G. Wenzl, M. Vogt, and P. Flecker. 1998. Mutational analysis of disulfide bonds in the trypsin-reactive subdomain of a Bowman-Birk-type inhibitor of trypsin and chymotrypsin-cooperative versus autonomous refolding of subdomains. Eur. J. Biochem. 251:854-862.
50. Montalto, M. C, C. D. Collard, J. A. Buras, W. R. Reenstra, R. McClaine, D. R. Gies, R. P. Rother, and G. L. Stahl. 2001. A keratin peptide inhibits mannose-binding lectin. J. Immunol. 166:4148-4153.
51. Roos, A., A. J. Nauta, D. Broers, M. C. Faber-Krol, L. A. Trouw, J. W. Drijfhout, and M. R. Daha. 2001. Specific inhibition of the classical complement pathway by C1q-binding peptides. J. Immunol. 167:7052-7059.
52. Budayova-Spano, M., W. Grabarse, N. M. Thielens, H. Hillen, M. Lacroix, M. Schmidt, J. C. Fontecilla-Camps, G. J. Arlaud, and C. Gaboriaud. 2002. Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. Structure 10:1509-1519.
53. Gaboriaud, C, V. Rossi, I. Bally, G. J. Arlaud, and J. C. Fontecilla-Camps. 2000. Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle. EMBO J. 19:1755-1765.
54. Rossi, V., S. Cseh, I. Bally, N. M. Thielens, J. C. Jensenius, and G. J. Arlaud. 2001. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and-2. J. Biol. Chem. 276:40880-40887.
55. Gulla, K. C, K. Gupta, A. Krarup, P. Gal, W. J. Schwaeble, R. B. Sim, C. D. O'Connor, and K. Hajela. 2010. Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 129:482-495.
56. Smith, G. P. 1985. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-1317.
57. Smith, G. P., and V. A. Petrenko. 1997. Phage display. Chem. Rev. 97:391-410.
58. Takahashi, K., W. C. Chang, M. Takahashi, V. Pavlov, Y. Ishida, L. La Bonte, L. Shi, T. Fujita, G. L. Stahl, and E. M. Van Cott. 2010. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology.
59. Gariani, T., J. D. McBride, and R. J. Leatherbarrow. 1999. The role of the P2' position of Bowman-Birk proteinase inhibitor in the inhibition of trypsin: studies on P2' variation in cyclic peptides encompassing the reactive site loop. Biochim. Biophys. Acta 1431:232-237.
60. Rawal, N., R. Rajagopalan, and V. P. Salvi. 2008. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement. J. Biol. Chem. 283:7853-7863.
61. Sahu, A., B. K. Kay, and J. D. Lambris. 1996. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J. Immunol. 157:884-891.
62. Sahu, A., A. M. Soulika, D. Morikis, L. Spruce, W. T. Moore, and J. D. Lambris. 2000. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J. Immunol. 165:2491-2499.
63. Katragadda, M., P. Magotti, G Sfyroera, and J. D. Lambris. 2006. Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J. Med. Chem. 49:4616-4622.
64. Kadam, A. P., and A. Sahu. 2010. Identification of Complin, a novel complement inhibitor that targets complement proteins factor B and C2. J. Immunol. 184:7116-7124.
65. Zhang, M., E. M. Alicot, I. Chiu, J. Li, N. Verna, T. Vorup-Jensen, B. Kessler, M. Shimaoka, R. Chan, D. Friend, et al. 2006. Identification of the target selfantigens in reperfusion injury. J. Exp. Med. 203:141-152.
66. Jordan, J. E., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of mannosebinding lectin reduces postischemic myocardial reperfusion injury. Circulation 104:1413-1418.